It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Case Law, evidence, Infringement, Injunction, Kluwer Patent Cases, Legislation, Litigation, Patents, Pharma, Pharmaceutical patent, United Kingdom
Evalve v Edwards Lifesciences [2020] EWHC 513 & 514 (Pat): The Limits of Public Interest
-
USA: Microsoft Corporation v. Proxyconn, Inc, United States Court of Appeals, Federal Circuit, Nos. 2014-1542, 16 June 2015
-
EveryMed AB v. Roche Diagnostics GmbH, Svea Court of Appeal Stockholm (Svea Hovrätt), 27 June 2012
-
Monsanto v. Nuziveedu: A Missed Opportunity by the Supreme Court?
-
Patent case: Edwards Lifesciences LLC v Boston Scientific Scimed Inc., United Kingdom
-
UK: Warner-Lambert Co LLC v. Actavis Group PTC, High Court of England and Wales, Chancery Division, Patents Court, HP-2014-000035 HP-2014-000021 HP-2014-001795, 10 September 2015
-
Top 3 posts of the autumn from our IP law blogs
-
Super-evident
-
Belgium: Online Offer for Sale Constitutes Patent Infringement
-
Breaking News: Germany’s Federal Constitutional Court pulls Emergency Break on UPC Agreement